Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > REGULATORY
REGULATORY
- MHLW to Set Up “Central Liaison Council” this Fiscal Year to Unify Criteria for Reviewing Medical Bills
February 15, 2013
- CSIMC OKs NHI Price Listing of 17 APIs; Peak Sales of 34 Billion Yen Projected for Eliquis
February 14, 2013
- EAD Director Kamata Encourages Generic Makers to Develop Overseas Operations
February 13, 2013
- Denotas Chewable for Hypocalcemia Associated with Administration of Denosumab Passes PAFSC 1st Committee
February 12, 2013
- Off-Label Use of Predonine for DMD Now Being Reimbursed
February 12, 2013
- Equa Gets Go-Ahead for Additional Concurrent-Use Indications of Insulin and Other Hypoglycemic Agents: PAFSC 1st Committee
February 8, 2013
- PAFSC First Committee Recommends Approval for Japan’s First FD Treatment Acofide
February 8, 2013
- Health Sciences Council to Upgrade Committee on Immunization to “Department on Preventive Vaccination and Vaccines”
February 7, 2013
- NIHS to Accelerate Medical Innovation Research
February 7, 2013
- MHLW to Launch Panel on Feb. 14 to Set New Rules for Online OTC Drug Sales
February 6, 2013
- New Council on Conflicts of Interest Holds 1st Meeting, Some Doctors Say Disclosure of Individual Payments, Recipient Names “Hasty”
February 5, 2013
- Takeda, KAKETSUKEN Apply for Funding Under Second Project to Develop and Manufacture New Flu Vaccines
February 4, 2013
- PAFSC's 2nd Committee Recommends Approval for Arzerra
February 1, 2013
- CRO Association to Compile Guidelines for Third-Party Outsourcing after GCP Revision
February 1, 2013
- Government Allocates 9 Billion Yen in FY2013 Budget to Boost Reviews and Safety Measures of Pharmaceutical Products
January 31, 2013
- Japan Cabinet OKs FY2013 Budget, Social Security Outlays Nearly 29 Trillion Yen
January 30, 2013
- 13 Generic Makers Slapped with Improvement Order due to South Korean Supplier’s GMP Violation
January 30, 2013
- Membership of Committee on Non-Prescription Drugs to Be Evenly Split Between Medical, Pharmaceutical Communities
January 30, 2013
- Ordinary Diet Session Convenes; Bills to Amend Preventive Vaccination Law, Public Assistance Law Expected to Be Submitted
January 30, 2013
- Welfare Recipients Will Be Required to Use Generics from April 1; Those Who Request Original Drugs Will Be Asked to Give Reason
January 29, 2013
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…